Study held to see the effect of Ajmodadi Vati on Prameha with special reference to Diabetis Mellitus Type 2.

A single arm clinical study to evaluate the efficacy add on effect of Ajmodadi vati in the managment of Prameha with special reference to Diabetis mellitus Type2

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/04/051266

Enrollment

Registered

2023-04-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patient with fasting blood sugar >126mg/dl upto 200mg/dl and post prandial blood sugar >200mg/dl upto 450mg/dl

Exclusion criteria

Exclusion criteria: Diabetes mellitus type 2 Acromegaly cushings syndrome and pancreatic disorders Pregnant and lactating mothers Patients with known case of Diabetic nephropathy and retinopathy Patients with gastrointestinal disease liver disease and tumors cardiovascular disease acute myocardial infarction DKA hyperosmolar non ketotic diabetic coma

Design outcomes

Primary

Measure	Time frame
To evaluate the add on effect of Ajmodadi vati in the management of prameha.Timepoint: 30 days study, follow up on 15th and 30th day.	—

Secondary

Measure	Time frame
To evaluate the effectivness of Ajmodadi vati on signs and symptoms of Prameha. Timepoint: 30 days study, follow up on 15th and 30th day.	—

Countries

India

Contacts

Public ContactBhagwan Kakasaheb Muley

Dr.D.Y.Patil college of Ayurved and Research Center,,Pimpri pune 411018 Maharashtr

abhijitshekhar00@gmail.com9764546495

Outcome results